Home Cart Sign in  
Chemical Structure| 1313730-19-6 Chemical Structure| 1313730-19-6

Structure of TFLLR-NH2(TFA)
CAS No.: 1313730-19-6

Chemical Structure| 1313730-19-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TFLLR-NH2(TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.

Synonyms: TFLLR-NH2 trifluoroacetate salt

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TFLLR-NH2(TFA)

CAS No. :1313730-19-6
Formula : C33H54F3N9O8
M.W : 761.83
SMILES Code : [C@@H](NC(=O)[C@@H](N)[C@H](O)C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N)CCCNC(N)=N)CC1C=CC=CC=1.C(F)(F)(F)C(=O)O
Synonyms :
TFLLR-NH2 trifluoroacetate salt
MDL No. :MFCD05663482
InChI Key :QVNWOGSDGQDGHP-MKVNCOEFSA-N
Pubchem ID :71311619

Safety of TFLLR-NH2(TFA)

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of TFLLR-NH2(TFA)

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
COS-7 cells 3 µM 30 minutes To evaluate the antagonistic effect of F16357 on TFLLR-NH2-induced G-protein activation. Results showed that F16357 antagonized 3 μM TFLLR-NH2-induced [35S]-GTPγS binding with pKb values of 6.04. Br J Pharmacol. 2016 Jul;173(14):2224-36
COS-7 cells 1 µM 5 hours To evaluate the antagonistic effect of F16357 on TFLLR-NH2-induced SRE-luciferase activity. Results showed that F16357 antagonized 1 μM TFLLR-NH2-induced luminescence with a pKb value of 5.49. Br J Pharmacol. 2016 Jul;173(14):2224-36

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat Rat hindpaw edema model Intraplantar injection 0.01 – 0.1 mmol per paw Single injection, evaluated after 15 minutes To evaluate the effect of TFLLR-NH2 on vascular permeability and edema formation in rat hindpaw, showing a dose-dependent increase in vascular permeability and edema formation Br J Pharmacol. 1999 Apr;126(8):1856-62
Mice H1N1 influenza virus infection model Intranasal administration 50 μM Administered on days 0, 2, and 3 post-infection PAR1 activation increased weight loss and mortality in H1N1-infected mice, indicating PAR1 plays a significant role in influenza virus pathogenicity. J Clin Invest. 2013 Jan;123(1):206-14

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.31mL

0.26mL

0.13mL

6.56mL

1.31mL

0.66mL

13.13mL

2.63mL

1.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories